| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/24/2008 | US20080021081 e.g. 4'-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)-1,1'-biphenyl-4-carbonitrile; histamine-3 receptor ligand; neuroleptic agent, neurodegenerative diseases, cognition activator; attention-deficit hyperactivity disorder, schizophrenia, Alzheimer's disease, epilepsy, seizures, allergic rhinitis |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080021054 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 01/24/2008 | US20080021053 Heterocyclic Derivatives |
| 01/24/2008 | US20080021052 Novel glucokinase activators and methods of using same |
| 01/24/2008 | US20080021050 Compounds, compositions, and methods |
| 01/24/2008 | US20080021037 Isethionate salt of a selective cdk4 inhibitor |
| 01/24/2008 | US20080021028 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis |
| 01/24/2008 | US20080021024 Metalloprotease inhibitors |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019922 Quinazoline derivatives, their preparation, their use, and medicaments comprising them |
| 01/24/2008 | US20080018237 Nitrogen-containing heterocyclic derivatives and organic electroluminescence device using the same |
| 01/24/2008 | DE19934799B4 Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten Chiral smectic liquid crystal composition and its use in active matrix display with high contrast |
| 01/24/2008 | CA2657745A1 Pyrimidine derivatives and their use as pesticides |
| 01/24/2008 | CA2657260A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1879900A2 Sulfoximine-pyrimidine macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer |
| 01/23/2008 | EP1879871A1 New heterocyclylethylamide derivatives |
| 01/23/2008 | EP1879870A1 Antitumoral tetrahydro-pyrimidines |
| 01/23/2008 | EP1879864A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 01/23/2008 | EP1644339B1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 01/23/2008 | EP1567498B1 Mandelic acid derivatives |
| 01/23/2008 | EP1556360B1 Electroluminescent device |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1322651B1 Bicyclic heteroaromatic compounds |
| 01/23/2008 | CN101111487A Processes for producing 4-aminoquinazolines |
| 01/23/2008 | CN101111484A Process for the manufacture of a precursor of vitamin b* |
| 01/23/2008 | CN101111250A Substituted 5-phenyl pyrimidines i in therapy |
| 01/23/2008 | CN100363364C Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7321033 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | US7320979 Diseases which respond to influencing by dopamine D3 receptor antagonists or agonists, diseases of the central nervous system and disturbances of kidney function; N-[6-(4-Allylpiperazin-1-yl)pyridin-3-yl]-4-isopropylbenzenesulfonamide |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/17/2008 | WO2008008747A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008008059A1 Anti-cancer agents ans uses thereof |
| 01/17/2008 | WO2008006560A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2007125405A3 Substituted 2-amino-fused heterocyclic compounds |
| 01/17/2008 | WO2007120669A8 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | US20080015353 Process for production of 4-acetylpyrimidines and crystals thereof |
| 01/17/2008 | US20080015256 Tetralin and indane derivatives and uses thereof |
| 01/17/2008 | US20080015208 3-Fluoro-N-(5-ureidomethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide; serotonin receptors 5-HT6 and 5-HT2A ligand; neurodegenerative disorders; antidepressant, anxiolytic agent; Parkinson's disease, Huntington's disease, manic depression, psychoses, epilepsy, obesity, drug abuse |
| 01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015192 Inhibitors of polo-like kinases |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015182 Potent PARP Inhibitors |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | DE102006031224A1 New sulfoximine-substituted pyrimidines useful for treating e.g. diseases caused by inflammatory, allergic or proliferative processes, oncological diseases, cancer, eye, autoimmune and neurodegerative diseases |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2657908A1 Benzofuro- and benzothienopyrimidine modulators of the histamine h4 receptor |
| 01/17/2008 | CA2657381A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhibitors |
| 01/17/2008 | CA2657062A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878726A1 Substituted sulphoximines as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same and uses of the same |
| 01/16/2008 | EP1878725A2 Pyrimidine derivatives and their use as CB2 modulators |
| 01/16/2008 | EP1877386A1 Herbicidally active phenylsulphonyl-urea |
| 01/16/2008 | EP1877385A1 Pyrimidines and pyrazines useful as modulators of ion channels |
| 01/16/2008 | EP1877384A2 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids |
| 01/16/2008 | EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 01/16/2008 | EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 01/16/2008 | EP1786823B1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 01/16/2008 | EP1340748B1 Quinazoline derivatives and drugs |
| 01/16/2008 | CN101107234A HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives |
| 01/16/2008 | CN101106998A Mitotic kinesin inhibitors |
| 01/16/2008 | CN101104617A Dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 01/16/2008 | CN101104608A Solanesol derivative, preparation and application thereof |
| 01/16/2008 | CN101104605A N-(4-chloro-6-methoxylpyrimidin-2-yl)-2,4-dichlorophenyloxyacetamide and its preparation method, application and agricultural composition |
| 01/16/2008 | CN101104604A Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 01/16/2008 | CN100361979C Process for preparing the calcium salt of rosuvastatin |
| 01/16/2008 | CN100361978C 2-pyrimidine oxy-N-aryl 7-nitrile or organic phosphate benzylamine compound, its production and use thereof |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319103 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/10/2008 | WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008003412A1 The use of 1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 01/10/2008 | US20080009623 Pyrimidine compounds |
| 01/10/2008 | US20080009622 Method for producing pyrimidine compound |
| 01/10/2008 | US20080009509 Quinazoline Derivatives For Inhibiting Cancer Cell Growth And Method For The Preparation Thereof |
| 01/10/2008 | US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid |
| 01/10/2008 | US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 01/10/2008 | US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates |
| 01/10/2008 | US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings |
| 01/10/2008 | CA2657702A1 Quinazolines and related heterocyclic comp0unds, and their therapeutic use |
| 01/10/2008 | CA2656622A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656618A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656307A1 Use of 1,4-diaryldihydropyrimidin-2-one derivatives for the treatment of pulmonary arterial hypertension |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1874738A1 Pyrimidines reacting with o6-alkylguanine-dna alkyltransferase |
| 01/09/2008 | EP1874733A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators |
| 01/09/2008 | EP1874724A2 Phenyl ethyne compounds |
| 01/09/2008 | EP1874117A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |